Comparison of Once-Daily Administration of Edoxaban and Rivaroxaban in Asian Patients with Atrial Fibrillation

It is unclear whether the two once-daily dosing non-vitamin K antagonist oral anticoagulants (NOACs), edoxaban and rivaroxaban, have similar effectiveness and safety in Asian patients with non-valvular atrial fibrillation (AF). This study aimed to compare the effectiveness and safety of edoxaban and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, So-Ryoung, Choi, Eue-Keun, Han, Kyung-Do, Jung, Jin-Hyung, Oh, Seil, Lip, Gregory Y. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491445/
https://www.ncbi.nlm.nih.gov/pubmed/31040359
http://dx.doi.org/10.1038/s41598-019-43224-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6491445/
https://www.ncbi.nlm.nih.gov/pubmed/31040359
http://dx.doi.org/10.1038/s41598-019-43224-4

Ejemplares similares